267 related articles for article (PubMed ID: 31293986)
1. Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice.
Zhou P; Li Z; Xu D; Wang Y; Bai Q; Feng Y; Su G; Chen P; Wang Y; Liu H; Wang X; Zhang R; Wang Y
Front Cell Infect Microbiol; 2019; 9():225. PubMed ID: 31293986
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
Cario E
Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
[TBL] [Abstract][Full Text] [Related]
3. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S
Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144
[TBL] [Abstract][Full Text] [Related]
4. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
6. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
7. Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.
Zhou P; Zhang R; Wang Y; Xu D; Zhang L; Qin J; Su G; Feng Y; Chen H; You S; Rui W; Liu H; Chen S; Chen H; Wang Y
Oncotarget; 2017 Dec; 8(67):111144-111160. PubMed ID: 29340044
[TBL] [Abstract][Full Text] [Related]
8. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
9. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
11. TLR signaling modulates side effects of anticancer therapy in the small intestine.
Frank M; Hennenberg EM; Eyking A; Rünzi M; Gerken G; Scott P; Parkhill J; Walker AW; Cario E
J Immunol; 2015 Feb; 194(4):1983-95. PubMed ID: 25589072
[TBL] [Abstract][Full Text] [Related]
12. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways.
Wei L; Wen XS; Xian CJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502383
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y
Clin Cancer Res; 2009 Jul; 15(13):4348-55. PubMed ID: 19509138
[TBL] [Abstract][Full Text] [Related]
15. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
Kwon J; Yoon HJ; Kim JH; Lee TS; Song IH; Lee HW; Kang MC; Park JH
Oncol Rep; 2014 Sep; 32(3):1188-92. PubMed ID: 24993015
[TBL] [Abstract][Full Text] [Related]
17. [Effect of intratumor heterogeneity of esophageal squamous cell carcinoma on chemotherapy sensitivity].
Sun L; Wu W; Yan M; Han PL; Zhan X; Ma XW; Cao XG; Zhao S; Gao F; Qi Y; Cao W
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):657-663. PubMed ID: 28926893
[No Abstract] [Full Text] [Related]
18. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
19. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
[TBL] [Abstract][Full Text] [Related]
20. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
